Cargando…

Role of tirofiban with dual antiplatelet therapy in patients with STEMI undergoing primary PCI

Detalles Bibliográficos
Autor principal:	Türker, Yasin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Kare Publishing 2016
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5336952/ https://www.ncbi.nlm.nih.gov/pubmed/26574767 http://dx.doi.org/10.5152/AnatolJCardiol.2015.6654

Ejemplares similares

The effects of tirofiban infusion on clinical and angiographic outcomes of patients with STEMI undergoing primary PCI
por: Kaymaz, Cihangir, et al.
Publicado: (2016)

Clinical efficacy and safety of tirofiban combined with conventional dual antiplatelet therapy in ACS patients undergoing PCI
por: Guo, Yong-zhe, et al.
Publicado: (2021)

High Bolus Tirofiban vs Abciximab in Acute STEMI Patients Undergoing Primary PCI – The Tamip Study
por: Balghith, Mohammed A.
Publicado: (2012)

Safety of tirofiban and dual antiplatelet therapy in treating intracranial aneurysms
por: Samaniego, Edgar A, et al.
Publicado: (2019)

Effect of prehospital treatment in STEMI patients undergoing primary PCI
por: Fabris, Enrico, et al.
Publicado: (2022)

New guidelines on primary PCI for patients with STEMI: changing insights
por: van der Wall, E.E.
Publicado: (2015)

Efficacy and safety of tirofiban bridge as an alternative to suspension of dual antiplatelet therapy in patients undergoing surgery: a systematic review
por: Riscado, Lorrane Vieira Siqueira, et al.
Publicado: (2021)

Will intravenous paracetamol crush fentanyl in patients undergoing PCI for STEMI?
por: ten Berg, J. M., et al.
Publicado: (2019)

Complementary Pharmacotherapy for STEMI Undergoing Primary PCI: An Evidence-Based Clinical Approach
por: Fabris, Enrico, et al.
Publicado: (2022)

Optimal duration for dual antiplatelet therapy with COMBO dual therapy stent
por: Huseynov, Aydin, et al.
Publicado: (2019)

Predictors of ST Depression Resolution in STEMI Patients Undergoing Primary PCI and Its Clinical Significance
por: Ghaffari, Samad, et al.
Publicado: (2020)

Impact of COVID-19 pandemic on STEMI undergoing primary PCI treatment in Beijing, China
por: Gong, Xuhe, et al.
Publicado: (2022)

Prolonged dual antiplatelet therapy for Chinese ACS patients undergoing emergency PCI with drug-eluting stents: Benefits and risks
por: Zhang, Yong, et al.
Publicado: (2023)

Tirofiban usage and prognosis after myocardial infarction
por: Eyüboğlu, Mehmet
Publicado: (2016)

Prasugrel or ticagrelor relative to clopidogrel in triple-antiplatelet treatment combined with glycoprotein IIb/IIIa inhibitor for patients with STEMI undergoing PCI: a meta-analysis
por: Wang, Zhe, et al.
Publicado: (2020)

Tailored Antiplatelet Therapy in Patients Undergoing PCI: Is Rapid Bedside Genetic Testing the Answer?
por: Faxon, David P.
Publicado: (2020)

Assessment of Growth Differentiation Factor 15 Levels on Coronary Flow in Patients with STEMI Undergoing Primary PCI
por: Dogdu, Orhan
Publicado: (2020)

Tirofiban shows better platelet inhibition in diabetic patients during PCI procedures
Publicado: (2010)

Dual antiplatelet agents and Rivaroxaban for massive intracoronary thrombus in STEMI
por: Jamal, Nasiruddin, et al.
Publicado: (2015)

Gastroprotection during long-term dual antiplatelet therapy: to give or not to give?
por: Sbrana, Francesco, et al.
Publicado: (2021)

Index of microcirculatory resistance predicts long term cardiac systolic function in patients with STEMI undergoing primary PCI
por: Qi, Yu, et al.
Publicado: (2021)

Outcome of manual thrombus aspiration for patients undergoing primary PCI for acute STEMI showing large thrombus burden
por: Elfekky, Ehab Mohamed, et al.
Publicado: (2021)

Monitoring the hemostasis with rotation thromboelastometry in patients with acute STEMI on dual antiplatelet therapy: First experiences
por: Samoš, Matej, et al.
Publicado: (2017)

Individualising dual antiplatelet therapy after percutaneous coronary intervention: the IDEAL-PCI registry
por: Christ, Günter, et al.
Publicado: (2014)

Stable Patients With STEMI Rarely Require Intensive-Care-Level Therapy After Primary PCI
por: Caddell, Andrew, et al.
Publicado: (2022)

Dual antiplatelet therapy does not scare away the erector spinae plane block
por: Smith, Christopher A., et al.
Publicado: (2019)

Prognosis of Atrial Fibrillation Patients Undergoing PCI According to Anticoagulants and Antiplatelet Agents
por: Yoon, Gwang-Seok, et al.
Publicado: (2021)

Impact of periprocedural morphine use on mortality in STEMI patients treated with primary PCI
por: Domokos, Dominika, et al.
Publicado: (2021)

Effect of Chinese national holidays and weekends versus weekday admission on clinical outcomes in patients with STEMI undergoing primary PCI
por: Tang, Liang, et al.
Publicado: (2017)

The effects of Anisodamine-Tirofiban Combined Therapy in acute myocardial infarction treated with Percutaneous Coronary Intervention (PCI)
por: Jiao, Yan, et al.
Publicado: (2022)

Does Opioid Addiction Influence Clinical and Angiographic Outcomes in STEMI Patients Undergoing Emergency PCI?
por: Amirpour, Afshin, et al.
Publicado: (2023)

Prasugrel-based De-Escalation of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention in Patients With STEMI
por: Ki, You-Jeong, et al.
Publicado: (2021)

Is the Duration of Dual Antiplatelet Therapy after Implantation of Drug-Eluting Stents the Longer the Better?
por: Huang, Qing-Yu, et al.
Publicado: (2015)

Platelet reactivity unit (PRU) in patients undergoing elective PCI: Rethinking the optimal cut point
por: Sharifi, Hassan, et al.
Publicado: (2017)

Optimizing antiplatelet / antithrombotic therapy
por: Srijithesh, P. R.
Publicado: (2010)

Analysis of the Best Timing for Applying Tirofiban in PCI Operation for the Patients with ST Segment Elevation Myocardial Infarction
por: Lei, Zhang, et al.
Publicado: (2015)

Safety of bridging antiplatelet therapy with the gpIIb-IIIa inhibitor tirofiban after emergency stenting in stroke
por: Lee, John-Ih, et al.
Publicado: (2017)

A prospective, observational, multicentre study comparing tenecteplase facilitated PCI versus primary PCI in Indian patients with STEMI (STEPP—AMI)
por: Victor, Suma M, et al.
Publicado: (2014)

Acute-Phase Inflammatory Reaction Predicts CMR Myocardial Scar Pattern and 2-Year Mortality in STEMI Patients Undergoing Primary PCI
por: Mester, Andras, et al.
Publicado: (2022)

Association of PCSK9 with inflammation and platelet activation markers and recurrent cardiovascular risks in STEMI patients undergoing primary PCI with or without diabetes
por: Song, Li, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_e5kd832ka6hrok7ui14vgrs71a